The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice.

Empagliflozin, a sodium-glucose co-transporter 2 inhibitor developed, has been shown to reduce cardiovascular events in patients with type 2 diabetes and established cardiovascular disease. Several studies have suggested that empagliflozin improves the cardiac energy state which is a partial cause of its potency. However, the detailed mechanism remains unclear.

Large Enhancement of the Single-Molecular Conductance of a Molecular Wire through a Radical Substituent.

Invited for the cover of this issue are Ryuto Yasui, Daiki Shimizu, and Kenji Matsuda at Kyoto University. The image depicts a comparison of the molecular conductance of radical-substituted and non-radical-substituted molecular wires evaluated by STM. Read the full text of the article at 10.

Large Enhancement of the Single-Molecular Conductance of a Molecular Wire through a Radical Substituent.

The single-molecular conductance between two π-conjugated wires with and without a radical substituent has been compared. Specifically, methyl- and iminonitroxide-substituted 4-(biphenyl-4-yl)pyridine wires bound onto a porphyrin template were subjected to scanning tunneling microscopy (STM) apparent-height measurement at the interface between highly oriented pyrolytic graphite (HOPG) and octan-1-oic acid. Statistical analysis of the STM images revealed that the radical-substituted wire has 3.